Trials / Completed
CompletedNCT04683185
A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Japanese Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of multiple ascending oral doses of E6742 in Japanese healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E6742 | E6742 tablets. |
| DRUG | Placebo | E6742-matched placebo tablets. |
Timeline
- Start date
- 2020-12-28
- Primary completion
- 2021-06-21
- Completion
- 2021-06-21
- First posted
- 2020-12-24
- Last updated
- 2021-07-20
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04683185. Inclusion in this directory is not an endorsement.